AFP and hepatocellular carcinoma: Therefore, in this study, we evaluated the prognostic utility of individual serum biomarkers (AFP, AFP-L3%, and DCP) and seven composite models (GALAD, GAAP, ASAP, BALAD, BALAD-2, Doylestown algorithm, and aMAP) using data from a biobank-based cohort of patients with HCC.